Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers

NCT00409006

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, South Korea
View Trial Details
Completed

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

NCT00544960

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Durham, North Carolina, United States
  • Research Site Arkhangelsk, Russia
  • Research Site Chelyabinsk, Russia
  • Research Site Kaliningrad, Russia
View all 18 locations
View Trial Details
Completed

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

NCT00440414

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • 401 Military Hospital, Medical Oncology Unit Athens, Greece
  • Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece
  • IASO General Hospital of Athens, 1st Department of Medical Oncology Athens, Greece
View Trial Details
Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00423254

Conditions
Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
Locations
  • Arizona Cancer Center Tuscon, Arizona, United States
  • Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States
  • H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States
  • Nevada Cancer Institute Sparks, Nevada, United States
View Trial Details

Related conditions